NCT01396668View on ClinicalTrials.gov

Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine, cisplatin, capecitabine

Gemcitabine: 1000mg/㎡ (day 1, 8), cisplatin 60mg/㎡ (day 1) Capecitabine: 650mg/㎡ twice a day, during radiotherapy Gemcitabine: 1000mg/㎡ (day 1, 8)

Trial Locations (2)

Unknown

Seoul National University Bundang Hospital, Seongnam

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01396668 - Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter